---
title: "Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress | TVTX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288736170.md"
description: "Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress | TVTX Stock News"
datetime: "2026-06-04T06:10:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288736170.md)
  - [en](https://longbridge.com/en/news/288736170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288736170.md)
---

# Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress | TVTX Stock News

Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress | TVTX Stock News

### Related Stocks

- [TVTX.US](https://longbridge.com/en/quote/TVTX.US.md)

## Related News & Research

- [Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News](https://longbridge.com/en/news/289514280.md)
- [3 Stocks That May Be Priced Below Their Estimated Value In June 2026](https://longbridge.com/en/news/289086832.md)
- [09:42 ETNational Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making](https://longbridge.com/en/news/289065527.md)
- [BNP Paribas Financial Markets Has $25.44 Million Stock Position in Travere Therapeutics, Inc. $TVTX](https://longbridge.com/en/news/288823155.md)
- [02:26 ETRenowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services](https://longbridge.com/en/news/289145514.md)